Topics are selected based on the group’s interest level and expert availability. Topics being considered: senolytics, stem cell transplants, muscle aging, thymus regeneration, microbiome, mitochondrial drugs, neurogenesis upregulation, exosomes, nootropics, medical tourism, therapeutic plasma exchange, Yamanaka factors, inflammaging modulators, Klotho, Vitamin D, microbiota transplants, atherosclerosis, gene therapy, deprenyl, hormone replacement therapy, skin aging, peptides, fasting, continuous glucose monitoring, HBOT, biomarkers/aging clocks, sleep, cancer, telomeres, spermidine, statins, antifibrotic agents, flagellin, oxytocin, NAD optimization, lipids, antioxidants, mitophagy, rapamycin, melatonin, Rejuvant, collagen, nutrition/diets, metformin, genomics, cross-link breakers, PEMF, biobanking, GDF-11/15, etc.
To make the best use of members’ time, we use a compressed format: 20 minutes individual reports on personal experimentation, group projects such as discounted purchase of services, 20 minutes presentation by a member or external expert; 20 minutes discussion.
All conversations in this group are confidential and off the record.
Reason is co-founder and CEO of Repair Biotechnologies. He has been an active angel investor in the longevity industry since its earliest days, with investments including Oisin Biotechnologies and Leucadia Therapeutics. He is a long-standing and well-connected patient advocate for aging research, involved in numerous fundraising and outreach initiatives conducted by organizations such as the Methuselah Foundation and SENS Research Foundation since the early 2000s. He is also the founder and writer of Fight Aging!, a noted news and commentary website in the biotechnology community. Prior to his involvement in the biotechnology industry, Reason was a consultant in the software industry. He holds Masters degrees in Astrophysics from the University of St. Andrews and Space Physics from Rice University.
Aaron King has been involved in various longevity projects for the last 10-15 years. He has written overviews of the network of longevity organizations as well as the landscape of scientific pathways in pursuit of longevity. After growing tired of being marooned on a rock in the middle of the pacific ocean, he moved from Maui to Palo Alto to be closer to the hub of research and discovery.
Allison Duettmann is the president and CEO of Foresight Institute. She directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Groups, Fellowships, Prizes, and Tech Trees. She founded Existentialhope.com, co-edited Superintelligence: Coordination & Strategy, co-authored Gaming the Future, and co-initiated The Longevity Prize. She advises non-profits, companies, and individuals.